PLRX
Pliant Therapeutics Inc
1.00$
+0.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.2% | +1.8% | -7.3% | -7.9% | -10.9% | -13.1% | -13.0% | -7.7% | -18.6% | -10.0% | -6.3% | |
| – | -5.4% | -3.1% | -8.6% | -8.4% | -11.6% | -14.1% | -14.1% | -8.2% | -20.0% | -11.0% | -6.7% | |
| – | +9.6% | +80.8% | -29.7% | -1.0% | -10.6% | +29.1% | -5.6% | +8.0% | -51.5% | -51.2% | +12.1% | |
| – | -5.6% | -2.4% | -9.5% | -7.4% | -12.1% | -14.1% | -14.0% | -8.0% | -21.0% | -10.5% | -7.5% | |
| – | +41.2% | -22.8% | +21.1% | -20.9% | +3.8% | -26.9% | -8.8% | -40.8% | -9.4% | +11.1% | -4.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.1% | +118.4% | +8.0% | +9.7% | -7.0% | -5.7% | -9.0% | -4.3% | -42.3% | -15.0% | +14.8% | |
| – | +4.1% | +6.5% | +1.8% | +29.2% | -16.9% | -15.1% | -27.0% | -14.4% | -7.1% | -36.7% | +59.1% | |
| – | -36.1% | -41.4% | -87.3% | +228.6% | +68.3% | +42.3% | +58.9% | -3.1% | +21.9% | +18.4% | +32.6% | |
| – | +34.9% | +61.7% | -55.7% | +112.2% | -13.5% | -5.7% | -75.4% | -65.0% | -1.0% | -24.6% | +322.9% | |
| – | +0.3% | +198.4% | +0.2% | +0.2% | +0.2% | +0.2% | +0.3% | +0.3% | – | – | – | |
| – | -5.9% | -7.7% | -10.2% | -11.9% | -12.1% | -15.4% | -14.4% | -9.0% | -9.5% | -8.9% | -11.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +0.5% | +0.3% | +0.6% | -0.3% | +1.1% | +0.3% | +0.0% | -0.1% | +0.7% | +0.2% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.